This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Validity of estimate of measure of effectiveness
The authors adopted bacterial growth as the measure of effectiveness. This appears to have been a valid measure of effectiveness. The sample size was small and no power calculations were reported. Hence, the sample size may have been insufficient to obtain robust results. No statistical analysis, to evaluate the significance of differences in outcomes between the two health technologies, was conducted. Therefore, the validity of the effectiveness analysis is questionable.
Validity of estimate of measure of benefit
No summary benefit measure was used in the analysis because a cost-minimisation approach was adopted.
Validity of estimate of costs
The economic perspective adopted was not stated clearly, but it is likely to have been that of the hospital. It is unclear from the study whether the cost analysis was handled credibly. Few details on the cost analysis were reported. The resource quantities and the unit costs were not reported, which may limit the generalisability of the economic analysis to other settings. The categories of costs included in the analysis were not reported clearly. It appears that the authors have limited their analysis to the cost of the epidural infusate solutions. It is also unclear what method was used to value the resources. The cost estimates are likely to be specific to the Yale New-Haven Hospital. Another drawback of the cost analysis was that statistical and sensitivity analyses were not performed on the costs. Consequently, the internal and external validity of the study may be low.
Other issues
A caveat to the study is the quality of the effectiveness data that can be obtained from this type of study design. A further caveat is the lack of a measure of benefits, which makes it difficult to draw comparisons with other studies and technologies necessary to help decision-makers in the allocation of resources.
The authors compared their findings with those of other research studies. They stated that this piece of research confirmed a prior trend of epidural solutions remaining sterile for longer than 24 hours. The authors did not report any further limitations of their study. The results were not reported selectively and the conclusions reflected the scope of the study. However, a more detailed costing exercise and description of resource use would have been more informative to the decision-maker and would aid transferability to other settings. The results of this study favour a change in policy to extend the room temperature hangtime expiry date. However, because of the study design and the scope of the costing, the magnitude of the savings should be considered with some caution.
